NEW YORK (Reuters Health) – In patients with hypertensive nephropathy and metabolic acidosis, alkali treatment reduces tubulointerstitial injury and slows the decline in glomerular filtration rate (GFR), a…
NEW YORK (Reuters Health) – High-dose atorvastatin does not protect against contrast-induced nephropathy (CIN) in patients with kidney disease, Italian researchers report. “Statins have recently been proposed for…
NEW YORK (Reuters Health) – The incidence of acute kidney injury after transcatheter aortic valve implantation (TAVI) is higher than 10%, a Canadian study shows. As reported in…
NEW YORK (Reuters Health) – In type 2 diabetics with multiple comorbidities, tight glycemic control does not provide the same cardiovascular benefits that it does in diabetics with…
NEW YORK (Reuters Health) – Chronic renal disease appears to reduce platelet responsiveness to clopidogrel, according to a Korean research team. Furthermore, increasing the dose of clopidogrel does…
NEW YORK (Reuters Health) – Adding angioplasty to medical therapy does not improve the outcomes of patients with renal-artery stenosis and carries substantial risks, according to a report…
NEW YORK (Reuters Health) – In kidney transplant recipients, bringing hemoglobin levels above 125 g/L with erythropoietin may increase mortality, according to a report in the November 6th…
NEW YORK (Reuters Health) – Blood transfusion is safe and may be beneficial in patients with acute decompensated heart failure, say researchers from Israel in the October American…
NEW YORK (Reuters Health) – In patients with hypertension, physicians should assess the presence of subclinical organ damage, an indication of high absolute risk for cardiovascular disease (CVD).…
NEW YORK (Reuters Health) – Percutaneous intervention may not be necessary for the majority of hypertensive patients with atherosclerotic renovascular disease. In a large retrospective study, researchers from…